ThermoLife International LLC v. Neogenis Labs Incorporated

District Court, D. Arizona·Decided November 1, 2021·No. 2:18-cv-02980·Unknown

Opinion

WO

ThermoLife International LLC, No. CV-18-02980-PHX-DWL

Plaintiff, ORDER

v.

Neogenis Labs Incorporated,

Defendant. Pending before the Court is HumanN’s motion to voluntarily dismiss its amended counterclaims without prejudice. (Doc. 243.) For the following reasons, the motion is granted. Because the parties are familiar with the background details of this case, which have been recounted at length in earlier orders, a full summary is unnecessary here. Cutting right to the chase, although this action between ThermoLife and HumanN has been pending since September 2018, ThermoLife filed a separate action against HumanN in February 2021 in the Western District of Texas (“the Texas Litigation”). Afterward, ThermoLife moved to dismiss its claims in this action without prejudice. (Doc. 202.) HumanN opposed this request, arguing that it would suffer “obvious prejudice were ThermoLife allowed to walk away from this case now, right before the close of discovery, only to re-file it down the road” (Doc. 209 at 6), but the Court concluded that ThermoLife’s dismissal request should be granted because, inter alia, “the Ninth Circuit has made clear that” the mere threat of future litigation “is insufficient to establish plain legal prejudice.” (Doc. 224 at 6.) The Court also predicted that “this action will not go away even if ThermoLife’s dismissal request is granted” because “HumanN has asserted counterclaims against ThermoLife that will remain pending regardless of what happens with ThermoLife’s claims.” (Id. at 9.) This prediction proved inaccurate. Almost immediately after the order granting ThermoLife’s dismissal request was docketed, HumanN took steps to stop litigating its amended counterclaims in this action. First, HumanN moved to transfer its amended counterclaims to the Western District of Texas (Doc. 227), but ThermoLife opposed this request (Doc. 232) and the Court eventually denied it, emphasizing that “[t]his case has been heavily litigated in the District of Arizona for several years,” that “the Court is intimately familiar with the parties, factual and procedural history, contested issues of law, and evidentiary record,” and that “transferring the lawsuit at this point in the litigation” would thus “undermine rather than promote judicial efficiency.” (Doc. 235 at 13.) After its transfer request was denied, HumanN filed the motion now pending before the Court—a motion to dismiss its amended counterclaims without prejudice. (Doc. 243.) HumanN also filed a motion for expedited treatment of its motion (Doc. 244), which the Court granted (Doc. 246), and the motion is now fully briefed. (Docs. 247, 248.)1 I. Legal Standard Rule 41(a)(2) of the Federal Rules of Civil Procedure provides: Except as provided in Rule 41(a)(1), an action may be dismissed at the plaintiff’s request only by court order, on terms that the court considers proper. If a defendant has pleaded a counterclaim before being served with the plaintiff’s motion to dismiss, the action may be dismissed over the defendant’s objection only if the counterclaim can remain pending for independent adjudication. Unless the order states otherwise, a dismissal under [Rule 41(a)(2)] is without prejudice.

Free access — add to your briefcase to read the full text and ask questions with AI

ThermoLife International LLC v. Neogenis Labs Incorporated, (D. Ariz. 2021).

ThermoLife International LLC v. Neogenis Labs Incorporated (ThermoLife International LLC v. Neogenis Labs Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related